Litcius/Paper detail

Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial

Koray Taşçılar, Melanie Hagen, Arnd Kleyer, David Simón, Michaela Reiser, Axel J. Hueber, Bernhard Manger, Matthias Englbrecht, Stephanie Finzel, Hans‐Peter Tony, Florian Schuch, Stefan Kleinert, J. Wendler, Monika Ronneberger, Camille P. Figueiredo, Jayme Fogagnolo Cobra, Martin Feuchtenberger, Martin Fleck, Karin Manger, Wolfgang Ochs, Matthias Schmitt-Haendle, Hanns‐Martin Lorenz, Hubert Nuesslein, Rieke Alten, Klaus Krüger, Jörg Henes, Georg Schett, Jürgen Rech

2021The Lancet Rheumatology31 citationsDOI

Topics & Concepts

Rheumatoid arthritisMedicineTaperingInternal medicineArthritisAntirheumatic drugsOpen labelRandomized controlled trialAntirheumatic AgentsPhysical therapyComputer graphics (images)Computer scienceRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchMusculoskeletal Disorders and Rehabilitation
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial | Litcius